562 THE JAK INHIBITOR TOFACITINIB RESCUES INTESTINAL BARRIER DEFECTS AND DISRUPTED EPITHELIAL-MACROPHAGE CROSSTALK CAUSED BY LOSS OF PTPN2 ACTIVITY IN VITRO AND IN VIVO.
| Autor: | Sayoc-Becerra, Anica, Spalinger, Marianne, Ordookhanian, Christ, Santos, Alina, Canale, Vinicius, King, Stephanie J., Scharl, Michael M., Krishnan, Moorthy, McCole, Declan F. |
|---|---|
| Zdroj: | In Gastroenterology May 2020 158(6) Supplement 1:S |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|